InvestorsHub Logo
Followers 9
Posts 1462
Boards Moderated 0
Alias Born 07/20/2012

Re: None

Saturday, 12/20/2014 9:10:12 PM

Saturday, December 20, 2014 9:10:12 PM

Post# of 687336
The delays with L are discouraging, but there is still a lot of potential upside value with Direct while we await completion of the L trial.

The current price is still attractive as a speculation on Direct alone. If additional phase 1 results continue to align with the positive tumor responses showcased to date, we will see increased interest and buying in 2015.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News